PI3Kβは,PTEN欠乏性乳がんにおける免疫回避を制御する
Johann S Bergholz1,2,3, Qiwei Wang1,2,3, Qi Wang1,4
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nature
|April 19, 2023
まとめ
PTEN腫瘍抑制遺伝子の喪失は 癌を助長する PTEN欠乏症の腫瘍におけるPI3Kβの抑制は免疫反応を誘発し,腫瘍の成長を抑制し,免疫療法の有効性を高めます.
科学分野:
- 腫瘍学
- 免疫学
- 分子生物学
背景:
- PTEN腫瘍抑制剤の喪失は多くのがんに共通する要因です.
- PTENはPI3Kシグナリングを否定的に調節し,PI3KβはPTEN欠乏性腫瘍に関与する.
- PI3Kβ活性とPTEN喪失がんの腫瘍進行を結びつけるメカニズムは完全に理解されていません.
研究 の 目的:
- PTEN欠乏症の侵襲性乳がんにおけるPI3Kβの役割を調査する.
- PI3Kβが抗腫瘍免疫に影響を与えるメカニズムを解明する.
- PI3Kβ抑制の治療の可能性を評価する.
主な方法:
- PtenとTrp53の切除による侵入性乳がんの遺伝子組み換えマウスモデルを使用した.
- 免疫能力のあるマウスと免疫欠陥マウスの腫瘍増殖に対する遺伝的PI3Kβ不活性化の影響を評価した.
- STAT3を含む下流信号伝達経路と免疫刺激分子発現を調査した.
- 薬学的PI3Kβ抑制と免疫療法との組み合わせの有効性を評価した.
主要な成果:
- PI3Kβの遺伝的不活性化により,強固な抗腫瘍免疫反応が誘発され,免疫能力のあるマウスの腫瘍の成長が中止された.
- PI3Kβの不活性化により,STAT3のシグナル伝達が低下し,PTEN- null腫瘍における免疫刺激分子発現が増加した.
- 薬学的PI3Kβ阻害は抗腫瘍免疫を誘発し,免疫療法と連携した.
- 完全な反応を達成したマウスは免疫記憶を示し,後の腫瘍再挑戦を拒絶した.
結論:
- PI3Kβは,STAT3信号と免疫応答を調節することによって,PTEN- null腫瘍における免疫脱出を制御する.
- PI3Kβ阻害剤と免疫療法の組み合わせは,PTEN欠乏性乳がんに対する有望な治療戦略です.
- この研究では,PTENの喪失,STAT3の活性化,がんにおける免疫回避との間の分子関連が明らかになりました.
さらに関連する動画
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.1K
関連する概念動画
01:22PI3K/mTOR/AKT Signaling Pathway
3.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:20The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K